A Clinical Study on the Laryngeal Cancer

Lee, Jong Duk; Lee, Kang Dae; Lee, Woo Chong; Yim, Yong Soo; Lee, Bong Hee; Lee, Cheong Sam; Yu, Tai Hyun

doi:10.35420/jcohns.1995.6.1.69

J Clin Otolaryngol Head Neck Surg 1995; 6(1):69-76

pISSN: 1225-0244, eISSN: 2713-833X

DOI: https://doi.org/10.35420/jcohns.1995.6.1.69

원저

후두암의 임상적 고찰

이종덕¹, 이강대¹, 이우종¹, 임용수¹, 이봉희¹, 이정삼¹, 유태현¹

A Clinical Study on the Laryngeal Cancer

Jong Duk Lee¹, Kang Dae Lee¹, Woo Chong Lee¹, Yong Soo Yim¹, Bong Hee Lee¹, Cheong Sam Lee¹, Tai Hyun Yu¹

Author Information & Copyright ▼

¹고신대학교 의과대학 이비인후과학교실

¹Department of Otolaryngology, College of Medicine, Kosin University

© Copyright 1995 The Busan, Ulsan, Gyeoungnam Branch of Korean Society of Otolaryngology-Head and Neck Surgery. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Published Online: May 31, 2020

ABSTRACT

The authors experienced 127 cases of laryngeal cancer for recent 8 years and analyzed treatment results as follows.

Glottic region was predominant as 52.8%, supraglottic 46.5%, subglottic 0.7% and advanced cases such as stage III, IV were 69.3% of the patients.
Cervical metastasis was observed 42.5% of the patients. The rate of cervical metastasis according to T-stage was 56.7% in T4, 48.9% in T3, 37.5% in T2 and 11.2% in T1. There were more common in supraglottic than glottic cancer about 4 times.
Initial treatment modalities were surgery only in 20.5%, radiation only in 31.5%, and combined surgery with postoperative radiation in 45.7%.
Overall 5-year survival rate was 52.6%, and showed 80.7% in stage I, 56.2% in stage II, 48.3% in stage III, and 44.8% in stage IV.
Glottic cancer showed better prognosis (5-year survival rate 65.2%) than supraglottic cancer(5-year survival rate 39.6%).
5-year survival rate according to treatment modality was 78.7% in surgery only group, 53.8% in radiation only group, and 48.5% in surgery with postoperative radiation group.
In cases of cervical metastasis, 5-year survival rate was decreased to 39.5%.

Keywords: Larygeal cancer; treatment modality; 5-year survival rate